Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Erlotinib and Docetaxel in NSCLC
NCT00908336Phase 2Unknown
- Sponsor
- Hospital Universitari Arnau de Vilanova
- Start
- Mar 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Hospital Universitari Arnau de Vilanova. Status: unknown.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00908336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908336.